Using cutting-edge drug design to beat cancer
John Spencer is a medicinal chemist at the forefront of drug discovery. He’s using our funding to tackle an age old cancer problem- the p53 protein.
Normally on our side, if p53 becomes faulty then cancer can develop. But scientists have found it hard to create a successful treatment targeting p53. Luckily, Dr Spencer has a few tricks up his sleeve. He is using his skills to fine-tune new compounds which could help stabilize faulty ‘wobbly’ p53. If successful, this truly pioneering research could help to establish exciting new possibilities in cancer treatments.